RNA
NASDAQ · Biotechnology
Avidity Biosciences Inc
$8.43
+0.11 (+1.32%)
Performance
1D
—
1W
+1.93%
1M
+6.31%
3M
-31.13%
6M
-36.38%
1Y
-87.92%
YTD
-88.31%
Open$8.31
Previous Close$8.32
Day High$8.56
Day Low$8.23
52W High$73.06
52W Low$7.49
Volume—
Avg Volume205.9K
Market Cap184.22M
P/E Ratio—
EPS$-5.04
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$9.47
Below
SMA 200
$19.91
Below
RSI (14)
72.2
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 24.23M | 15.30M | 2.36B |
| Net Income | -64,431,182 | -36,599,383 | -651,372,475 |
| Profit Margin | -265.9% | -252.6% | -27.6% |
| EBITDA | -64,179,463 | -38,481,753 | -865,943,607 |
| Free Cash Flow | — | — | -400,975,764 |
| Rev Growth | +58.4% | +58.4% | +6.9% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |